Bimodal effect of interferon-β on astrocyte proliferation and survival: Importance of nuclear factor-κB

Journal of Neuroimmunology

Volumn 226, Issue 1-2, 2010, Pages 73-80

  Barca, Olga ^a   Devesa Peleteiro, Pablo ^a   Seoane, Marcos ^a   Señarís, Rosa Ma ^a   Arce, Víctor M ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Astrocyte proliferation; Astrocyte survival; Inferferon beta; Multiple sclerosis; Nuclear factor kappa beta; Tumor necrosis factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RECOMBINANT BETA INTERFERON; BENZYLOXYCARBONYL-VALYL-ASPARTIC ACID FLUOROMETHYL KETONE; BETA INTERFERON; BROXURIDINE; ENZYME INHIBITOR; IMMUNOLOGIC FACTOR; ONCOPROTEIN; PEPTIDE CHLOROMETHYL KETONE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLIA; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; ANIMAL; ANIMAL EMBRYO; BRAIN CORTEX; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; NONPARAMETRIC TEST; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; ASTROCYTES; BROMODEOXYURIDINE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; ENZYME INHIBITORS; IMMUNOLOGIC FACTORS; INTERFERON-BETA; NF-KAPPA B; ONCOGENE PROTEIN V-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC;

EID: 77956343623     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.05.036     Document Type: Article

References (44)

1. Aaronson D.S., Horvath C.M. A road map for those who don't know JAK-STAT. Science 2002, 296:1653-1655.
2. Ambrosini E., Remoli M.E., Giacomini E., Rosicarelli B., Serafini B., Lande R., Aliosi F., Coccia E.M. Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 2005, 64:706-715.
3. Bannerman P., Hahn A., Soulika A., Gallo V., Pleasure D. Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia. Glia 2007, 55:57-64.
4. Barca O., Ferré S., Seoane M., Prieto J.M., Lema M., Señarís R., Arce V.M. Interferon beta promotes survival in primary astrocytes through phosphatidylinositol 3-kinase. J. Neuroimmunol. 2003, 139:155-159.
5. Barca O., Seoane M., Ferré S., Prieto J.M., Lema M., Señarís R., Arce V.M. Mechanisms of interferon β-induced survival in fetal and neonatal primary astrocytes. Neuroimmunomodulation 2007, 14:39-45.
6. Barca O., Costoya J.A., Señarís R.M., Arce V.M. Interferon-beta protects astrocytes against tumour necrosis factor-induced apoptosis via activation of p38 mitogen-activated protein kinase. Exp. Cell Res. 2008, 314:2231-2237.
7. Bayas A., Gold D. Lessons from 10years of interferon beta-1b (Betaferon/Betaseron) treatment. J. Neurol. 2003, 250(Suppl 4):3-8.
8. Biernacki K., Antel J.P., Blain M., Narayanan S., Arnold D.L., Prat A. Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis. Arch. Neurol. 2005, 62:563-658.
9. Billiau A. Anti-inflammatory properties of Type I interferons. Antivir. Res. 2006, 7:108-116.
10. Boutros T., Croze E., Yong V.W. Interferon-beta is a potent promoter of nerve growth factor production by astrocytes. J. Neurochem. 1997, 69:939-946.
11. Campbell K.J., Perkins N.D. Post-translational modification of RelA(p65) NF-kappaB. Biochem. Soc. Trans. 2004, 32:1087-1089.
12. Constantinescu C.S., Tani M., Ransohoff R.M., Wysocka M., Hilliard B., Fujioka T., Murphy S., Tighe P.J., Das Sarma J., Trinchieri G., Rostami A. Astrocytes as antigen-presenting cells: expression of IL-12/IL-23. J. Neurochem. 2005, 95:331-340.
13. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
14. Delhaye S., Paul S., Blakqori G., Minet M., Weber F., Staeheli P., Michiels T. Neurons produce type I interferon during viral encephalitis. Proc. Natl. Acad. Sci. U S A 2006, 103:7835-7840.
15. Du Z., Wei L., Murti A., Pfeffer S.R., Fan M., Yang C.H., Pfeffer L.M. Non-conventional signal transduction by type 1 interferons: the NF-kappaB pathway. J. Cell. Biochem. 2007, 102:1087-1094.
16. Dutta J., Fan Y., Gupta N., Fan G., Gélinas C. Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene 2006, 25:6800-6816.
17. Garrison J.I., Berens M.E., Shapiro J.R., Treasurywala S., Floyd-Smith G. Interferon-beta inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines. J. Neurooncol. 1996, 30:213-223.
18. Guthikonda P., Baker J., Mattson D.H. Interferon-beta-1-b (IFN-B) decreases induced nitric oxide (NO) production by a human astrocytoma cell line. J. Neuroimmunol. 1998, 82:133-139.
19. Holley J.E., Gveric D., Newcombe J., Cuzner M.L., Gutowski N.J. Astrocyte characterization in the multiple sclerosis scar. Neuropathol. Appl. Neurobiol. 2003, 29:434-444.
20. Jin S., Kawanokuchi J., Mizuno T., Wang J., Sonobe Y., Takeuchi H., Suzumura A. Interferon-beta is neuroprotective against the toxicity induced by activated microglia. Brain Res. 2007, 1179:140-146.
21. Kaltschmidt B., Widera D., Kaltschmidt C. Signaling via NF-kappaB in the nervous system. Biochim. Biophys. Acta 2005, 1745:287-299.
22. Kieseier B.C., Hartung H.P. Interferon-beta and neuroprotection in multiple sclerosis-facts, hopes and phantasies. Exp. Neurol. 2007, 203:1-4.
23. Kraus J., Ling A.K., Hamm S., Voigt K., Oschmann P., Engelhardt B. Interferon-β stabilizes barrier characteristics of brain endothelial cells in vitro. Ann. Neurol. 2004, 56:192-205.
24. Lee S.C., Moore G.R., Golenwsky G., Raine C.S. Multiple sclerosis: a role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study. J. Neuropathol. Exp. Neurol. 1990, 49:122-136.
25. Lee Y.-S., Song Y.S., Giffard R.G., Chan P.H. Biphasic role of nuclear factor-κ B on cell survival and COX-2 expression in SOD1 Tg astrocytes after oxygen glucose deprivation. J. Cereb. Blood Flow Metab. 2006, 26:1076-1088.
26. Malik O., Compston D.A., Scolding N.J. Interferon-beta inhibits mitogen induced astrocyte proliferation in vitro. J. Neuroimmunol. 1998, 15:155-162.
27. Markowitz C.E. Interferon-beta: mechanism of action and dosing issues. Neurology 2007, 68(Suppl 4):8-11.
28. Mattson M.P., Meffert M.K. Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ. 2006, 13:852-860.
29. McLaurin J., Antel J.P., Yong V.W. Immune and non-immune actions of interferon-beta-1b on primary human neural cells. Mult. Scler. 1995, 1:10-19.
30. Mémet S. NF-kappaB functions in the nervous system: from development to disease. Biochem. Pharmacol. 2006, 72:1180-1195.
31. Niemelä J., Ifergan I., Yegutkin G.G., Jalkanen S., Prat A., Airas L. IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier. Eur. J. Immunol. 2008, 38:2718-2726.
32. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 2000, 343:938-952.
33. Okada K., Kuroda E., Yoshida Y., Yamashita U., Suzumura A., Tsuji S. Effects of interferon-beta on the cytokine production of astrocytes. J. Neuroimmunol. 2005, 159:48-54.
34. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., Donner D.B. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999, 401:82-85.
35. Préhaud C., Mégret F., Lafage M., Lafon M. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J. Virol. 2005, 79:12,893-12,904.
36. Rani M.R., Ransohoff R.M. Alternative and accessory pathways in the regulation of IFN-beta-mediated gene expression. J. Interferon Cytokine Res. 2005, 25:788-798.
37. Satoh J., Paty D.W., Kim S.U. Counteracting effect of IFN-beta on IFN-gamma-induced proliferation of human astrocytes in culture. Mult. Scler. 1996, 1:279-287.
38. Sättler M.B., Demmer I., Williams S.K., Maier K., Merkler D., Gadjanski I., Stadelmann C., Bähr M., Diem R. Effects of interferon-beta-1a on neuronal survival under autoimmune inflammatory conditions. Exp. Neurol. 2006, 201:172-181.
39. Sen R., Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 1986, 47:921-928.
40. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 1998, 67:227-264.
41. Stewart V.C., Land J.M., Clark J.B., Heales S.J. Pretreatment of astrocytes with interferon-alpha/beta prevents neuronal mitochondrial respiratory chain damage. J. Neurochem. 1998, 70:432-434.
42. Takekawa M., Adachi M., Nakahata A., Nakayama I., Itoh F., Tsukuda H., Taya Y., Imai K. p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J. 2000, 19:6517-6526.
43. Tani M., Glabinski A.R., Tuohy V.K., Stoler M.H., Estes M.L., Ransohoff R.M. In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. Am. J. Pathol. 1996, 148:889-896.
44. Tedeschi B., Barrett J.N., Keane R.W. Astrocytes produce interferon that enhances the expression of H-2 antigens on a subpopulation of brain cells. J. Cell Biol. 1986, 102:2244-2253.